Rare Disease Report

Treatment for MPS I - A Patient's Perspective

FEBRUARY 15, 2017
Erika Thiel

Erika Thiel of GeneSpotlight talks about her rare disease - Mucopolysaccharidosis (MPS) 1 - and  the limitations of the currently approved enzyme replacement therapy [Aldurazyme (laronidase)].

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.